Publications

• Managed Care Guidelines for Management of Chronic Kidney Disease
  
  [Full text available in Adobe PDF format]
  Provenzano, R, et al. Managed Care Guidelines for Management of Chronic Kidney Disease, Suppl. Managed Care, Vol. 12, No. 3, March 2003.
• Comparison of Vancomycin Versus Cefazolin as Initial Therapy for Peritonitis in Peritoneal Dialysis Patients
  
  [Download full text article in Adobe PDF format]
  Khairullah, Q., Provenzano, R., Ahmed, A., Tayeb, T., Balakrisnan, B., Comparison of Vancomycin Versus Cefazolin as Initial Therapy for Peritonitis in Peritoneal Dialysis Patients, In press, Perit Dial Int 2002; 22:339-344.
  
• Current Essentials of Diagnosis & Treatment in Nephrology and Hypertension
  
  [McGraw Hill Publisher Link]
  Provenzano, R., Anemia Management in Chronic Kidney Disease. "Current Essentials of Diagnosis & Treatment in Nephrology and Hypertension," Nissenson, A., Berns, J., Lerma, E. Editors, McGraw Hill Publishers, April 2007.
  BOOK OVERVIEW: CurrentDiagnosis & Treatment in Nephrology and Hypertension offers a practical, clinical review of the state-of-the-art approach to the management of kidney diseases and hypertension--in the popular CURRENTS format. You'll find coverage of all the major diseases and disorders plus all the leading therapies.
• Role of Current Immunosuppressant Agents, Infectious Diseases in Clinical Practice
  
  [View article listing on IDCP]
  Vigil, Karen J. MD; Pasumarthy, Anita MD; Johnson, Leonard B. MD; Sheppard, Theresa MSN; El-Ghoroury, Mohammed MD; del Busto, Ramon MD. Infectious Diseases in Clinical Practice. 15(3):171-173, May 2007.
  ABSTRACT: Nocardia infections are an important cause of morbidity and mortality in renal transplant recipients. There are no recent studies evaluating the characteristics of nocardiosis using current immunosuppressants. To determine the incidence and risk factors for infection, we performed a 5-year retrospective review and case control study of renal transplant recipients with nocardiosis at 2 renal transplant centers.
• Role of Aldosterone in Left Ventricular Hypertrophy among African-American Patients with End-Stage Renal Disease on Hemodialysis
  
  [View listing on Karger.com]
  Steigerwalt, S., Zafar, A., Mesiha, N., Gardin, J., Provenzano, R., Role of Aldosterone in Left Ventricular Hypertrophy among African-American Patients with End-Stage Renal Disease on Hemodialysis, American Journal of Nephrology 2007; 27:159-163.
  ABSTRACT: Recently, serum aldosterone levels have been reported to play a significant role in cardiac hypertrophy. One study of Japanese patients correlated aldosterone levels with the degree of left ventricular hypertrophy (LVH) in those undergoing hemodialysis. However, the role of aldosterone in LVH in non-Japanese patients with end-stage renal disease (ESRD) has not been established. 
• Prevalence and Treatment of Anemia with Once-Weekly Epoetin Alfa in Patients with Diabetes and Chronic Kidney Disease
  
  [Full text available on Oxford Journals]
  Lorber, D., Provenzano, R., McClellan, W., Prevalence and Treatment of Anemia with Once-Weekly Epoetin Alfa in Patients with Diabetes and Chronic Kidney Disease, Endocrine Practice, Vol. 12, No. 5, pp. 506-513, September/October 2006.
  ABSTRACT: The effectiveness of extended dosing of epoetin alfa beyond once-weekly (QW) has not been well explored in patients being treated for anaemia of chronic kidney disease (CKD). The current study was undertaken to assess the effectiveness of extended dosing in maintaining haemoglobin (Hb) levels in this population.
• Syndrome of Tubulointerstitial Nephritis and Uveitis: A Unique Entity or Example of Extra-Pulmonary Sarcoidosis
  
  [Full text available in Adobe PDF format]
  Topf, J., Babbar, N., Syndrome of Tubulointerstitial Nephritis and Uveitis: A Unique Entity or Example of Extra-Pulmonary Sarcoidosis. National Kidney Foundation Clinical Meetings, Orlando, FL, 2007.
• The Prevalence of Primary Aldosteronism in Diabetic Patients
  
  [Full text available on Oxford Journals]
  Jefic, D., Mohiuddin, N., Alsabbagh, R., Fadanelli, M., Steigerwalt, S., The Prevalence of Primary Aldosteronism in Diabetic Patients, The Journal of Clinical Hypertension, Vol. 8, No. 4, pp. 1-4, April, 2006.
  EXCERPT: Although primary aldosteronism (PA) has long been considered a rare cause of hypertension, recent reports suggest that the prevalence of PA among hypertensive patients may exceed 10%
• Disorders of Potassium Homeostatis
  
  [Text available on Google Books]
  Topf, J.M., and Asplin, J.R., “Disorders of Potassium Homeostasis.” Intensive Care in Nephrology, Murray, P., Brady, H., Hall, J., Editors, Chap. 23, pp.363-382, Taylor & Francis Publishers, 2006.
  ABOUT THIS BOOK: The field of intensive care in nephrology is a rapidly evolving one, with research beginning to translate into clinical guidelines and standards. This comprehensive text includes all pertinent topics related to ICU nephrology, including shock, respiratory failure, syndromes, pharmacology, various types of renal replacement therapies, toxicology, fluid management, potassium homeostasis, and more.
• Disorders of Calcium, Phosphorus, and Magnesium
  
  [Text available on Google Books]
  Topf, J.M. and Worcester, E., “Disorders of Calcium, Phosphorus, and Magnesium.” Intensive Care in Nephrology, Murray, P., Brady, H., Hall, J., Editors, Chap. 24, pp. 383-411, Taylor & Francis Publishers, 2006.
  ABOUT THIS BOOK: The field of intensive care in nephrology is a rapidly evolving one, with research beginning to translate into clinical guidelines and standards. This comprehensive text includes all pertinent topics related to ICU nephrology, including shock, respiratory failure, syndromes, pharmacology, various types of renal replacement therapies, toxicology, fluid management, potassium homeostasis, and more.
• Electrolyte Disorders in Critical Care
  
  [This book page on Amazon.com]
  Topf, J.M., Rankin, S., Murray, P., “Electrolyte Disorders in Critical Care.”  Principles of Critical Care, Third Edition,  Hall, J., Schmidt, G., Wood, L., Editors, Chap. 76, pp. 1161-1199, McGraw-Hill , 2005.
  ABOUT THIS BOOK: The new single volume format takes an organ system approach to critical care with sections addressing cardiovascular, pulmonary, neuropsychiatric, hematologic/oncologic, renal, and gastrointestinal disorders.
• Extended Epoetin Alfa Dosing as Maintenance Treatment for the Anemia of Chronic Kidney Disease
  
  [View article listing on Pubmed.gov]
  Provenzano, R., Bhaduri, S., Singh, A., Extended Epoetin Alfa Dosing as Maintenance Treatment for the Anemia of Chronic Kidney Disease: The PROMPT Study, Clinical Nephrology, Vol. 64, No. 2, pp. 113-123, August 2005.
  AIM: To determine whether extended epoetin alfa dosing schedules of up to once every four weeks are as effective as weekly dosing in maintaining hemoglobin (Hb) levels in patients with anemia of chronic kidney disease (CKD).
  
• A Single Center Experience in the Use of Polyurethaneurea Arteriovenous Grafts
  
  [View article listing on Pubmed.gov]
  Jefic, D., Reddy, P., Flynn, L., Provenzano, R.,  A Single Center Experience in the Use of Polyurethaneurea Arteriovenous Grafts, Nephrology News and Issues, Vol. 19, No. 8 , pp. 44-47, July 2005.
  BACKGROUND: Polytetrafluoroethylene (PTFE) grafts often require temporary catheters, which increase costs as well as risk of infection, bleeding, and poor blood flow. Polyurethaneurea (PUU) grafts can be cannulated within 24 hours of placement, avoiding the need for temporary catheters.
• Core Curriculum in Nephrology: Economics of Clinical Nephrology Practice
  
  [Full text available in Adobe PDF format]
  Provenzano, R., Nissenson, A., Core Curriculum in Nephrology: Economics of Clinical Nephrology Practice, American Journal of Kidney Diseases, Vol. 44, No. 1, pp. 168-178, July 2004.
  ABOUT: Economics of Clinical Nephrology Practice” emphasizes learning the information needed to make the best choices for clinical practice, and as a result having a productive and rewarding career as a clinical nephrologist.
• Once-Weekly Epoetin Alfa for Treating the Anemia of Chronic Kidney Disease
  
  [View article listing on isiknowledge.com]
  Provenzano, R., Garcia-Mayol, L., Suchinda, P., Von Hartitzsch, B., Woollen, S.B., Zabaneh, R., Fink, J.C. and the POWER Study Group, Once-Weekly Epoetin Alfa for Treating the Anemia of Chronic Kidney Disease, Clinical Nephrology, Vol. 61, No 6, pp. 392-405, June 2004.
  BACKGROUND AND AIM: Anemia occurs in approximately 47% of patients with chronic kidney disease (CKD) not on dialysis. Recombinant human erythropoietin (r-HuEPO, epoetin alfa) has been proven safe and effective for anemia treatment in patients with CKD using a three times-weekly regimen. The current study was conducted to evaluate the clinical safety and efficacy of a less frequent dosing regimen (once weekly) in this population.
• Early Detection of Prostate Cancer in the ESRD Population
  
  [View article listing on pubMed.gov]
  Khairullah, Q.T., Pamatmat, S.D., Chatha, M., Provenzano, R., Telang, D., Temple, M., Early Detection of Prostate Cancer in the ESRD Population, Clinical Nephrology, Vol. 61, No. 5, May 2004.
  BACKGROUND: There are currently no prostate cancer screening guidelines specific to the end-stage renal disease (ESRD) population. With this in mind, we evaluated the clinical usefulness of digital rectal examination (DRE), serum total prostate-specific antigen (PSA), prostate-specific antigen density (PSAD) and transrectal ultrasound (TRUS) in predicting prostate cancer in men with ESRD.
• The Value of Integrating a Vascular Surgeon into a Nephrology Practice
  
  [View article listing on pubmed.gov]
  Provenzano, R., Flynn, L., The Value of Integrating a Vascular Surgeon into a Nephrology Practice, Nephrology News & Issues, Vol. 17, No. 8, pp. 49-53, July 2003.
• Hyperkalemia in a Chronic Kidney Disease Clinic: Frequency, Risk Factors and Protective Agents
  
  Topf, J., Alumit, G., Hyperkalemia in a Chronic Kidney Disease Clinic: Frequency, Risk Factors and Protective Agents, American Society of Nephrology 39th Annual Meeting, San Diego, CA, 2006.
• The Nephrology Nurse's Role in Improved Care of Patients with Chronic Kidney Disease
  
  [Full article text available on Findarticles.com]
  Provenzano, R., Compton, A., Johnson, CA., The Nephrology Nurse’s Role in Improved Care of Patients with Chronic Kidney Disease, Nephrology Nursing Journal, Vol. 29, No. 4, pp. 331-336, (August) 2002.
  ABSTRACT: Several authors have advocated the use of multidisciplinary patient care teams to provide the most effective and efficient care for patients with CKD (Grady, Casde, & Sibley, 1996; Self et al., 1999). This article will review selected aspects of CKD management, describe the contributions of nephrology nurses practicing within a multidisciplinary CKD clinic, and discuss national CKD initiatives and educational materials that will assist nephrology nurses in caring for CKD patients.
  
• The Effect of Chronic Kidney Disease (CKD) on the Levels of Plasma and Urinary Aldosterone.
  
  Steigerwalt, S., Babbar, N., The Effect of Chronic Kidney Disease (CKD) on the Levels of Plasma and Urinary Aldosterone. The American Society of Hypertension Twenty-Second Annual Scientific Meeting & Exposition, Chicago, IL, 2007.
• Frequency of HB Testing and Anemia Diagnosis in Patients with Chronic Kidney Disease During Pre and Postdialysis Period.
  
  [Full text available in Adobe PDF format via ScienceDirect]
  Wish, J., Provenzano, R., Shulman, K., Law, A, Nassar, G., Frequency of HB Testing and Anemia Diagnosis in Patients with Chronic Kidney Disease During Pre and Postdialysis Period.  National Kidney Foundation Clinical Meetings, Orlando, FL, 2007.
• The Prevalence of Antiphospholipid Antibodies (APA) in Late Chronic Kidney Disease (CKD) and Incidence Following Initiation of Dialysis
  
  Topf, J., Shahab, H., Nagrecha, N., Mantena, S., The Prevalence of Antiphospholipid Antibodies (APA) in Late Chronic Kidney Disease (CKD) and Incidence Following Initiation of Dialysis, American Society of Nephrology 39th Annual Meeting, San Diego, CA, 2006
• Carnitine Effectiveness on Intradialytic Hypotension
  
  Topf, J., Alumit, G., Carnitine Effectiveness on Intradialytic Hypotension.  National Kidney Foundation Clinical Meetings, Orlando, FL, 2007.
• A Case of Biopsy Proven Spontaneous Cholesterol Embolism
  
  [Full text available from AJKD website]
  Topf, J., Babbar, N., A Case of Biopsy Proven Spontaneous Cholesterol Embolism. National Kidney Foundation Clinical Meetings, Orlando, FL, 2007.
• Thymoglobulin Induction for the Double Avoidance of Steroids and Calcineurin Inhibitors in Living-related Kidney Transplantation
  
  El-Ghoroury, M., Butcher, D., Shahab, H., Thymoglobulin Induction for the Double Avoidance of Steroids and Calcineurin Inhibitors in Living-related Kidney Transplantation, National Kidney Foundation Spring Clinical Meetings, Orlando, FL, 2007.